Plus Therapeutics (PSTV)
(Delayed Data from NSDQ)
$2.16 USD
-0.08 (-3.57%)
Updated May 10, 2024 04:00 PM ET
After-Market: $2.19 +0.03 (1.39%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth C Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/16/2024
Time: -- |
3/2024 | $-0.25 | 0.00% |
Earnings Summary
For their last quarter, Plus Therapeutics (PSTV) reported earnings of -$0.70 per share, beating the Zacks Consensus Estimate of $-0.78 per share. This reflects a positive earnings surprise of 10.26%. Look out for PSTV's next earnings release expected on May 16, 2024. For the next earning release, we expect the company to report earnings of -$0.25 per share, reflecting a year-over-year increase of 88.1%.
Earnings History
Price & Consensus
Zacks News for PSTV
Plus Therapeutics (PSTV) Reports Q4 Loss, Tops Revenue Estimates
PSTV: What are Zacks experts saying now?
Zacks Private Portfolio Services